SCHEMBL21139367

SCHEMBL21139367

CCCCCCC(NC(=O)/C=C/c1ccc(O)cc1)C(O)Oc1cc(O)cc2c1C(=O)CC(c1ccc(O)cc1)O2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 5/20 0.44
▸ ESR2 Q92731 5/20 0.44
▸ CYP3A4 P08684 4/20 0.44
▸ CYP19A1 P11511 4/20 0.44
▸ CYP1A1 P04798 4/20 0.44
▸ CYP1A2 P05177 4/20 0.44
▸ CYP1B1 Q16678 4/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CA4 P22748 2/20 0.44
▸ DPP4 P27487 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ CA7 P43166 2/20 0.44
▸ GSK3B P49841 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALOX12 P18054 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ SLCO2B1 O94956 1/20 0.44
▸ TTR P02766 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21140296 0.87 ESR1 (0.44) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139365 0.71 CYP19A1 (0.56) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL773766 0.69 TAS2R31 (0.72) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL799649 0.69 TAS2R31 (0.72) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL30641776 0.69 TAS2R31 (0.72) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139391 0.68 CYP19A1 (0.55) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL379369 0.68 CYP19A1 (0.65) CYP3A4CYP19A1CYP1A1CYP1A2CYP1B1
SCHEMBL21140118 0.67 CYP19A1 (0.52) ESR1ESR2CYP3A4CYP19A1CYP1A1
SCHEMBL21139388 0.67 CYP19A1 (0.56) ESR1ESR2CYP3A4CYP19A1CYP1A1
Naringenin SCHEMBL3820944 0.67 CYP19A1 (0.87) ESR1ESR2CYP3A4CYP19A1CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111265-A1 COMPOUNDS AND METHODS FOR TREATING CANCER SHARE GAL RESEARCH AND DEVELOPMENT LTD (IL) 2019-06-13 — — WO disclosed
Send feedback